ArticleDiagnostic cytopathology2026
Cytological Diagnosis of Primary Cardiac Angiosarcoma Presenting With Multiple Serous Effusions: A Case Report With Cell Block.
Article in Diagnostic cytopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac angiosarcoma (PCAS) is the most aggressive primary malignant cardiac tumor. Owing to the nonspecific nature of clinical symptoms, early detection, diagnosis, and treatment remain challenging. The tumor is characterized by high malignancy, a propensity for early metastasis, and an overall poor prognosis. We report a 42-year-old female presenting with abdominal distension and exertional dyspnea for 1 month, found to have a cardiac space-occupying lesion and multiple serous effusions on imaging. The final diagnosis of PCAS was established by combining cytomorphological analysis of the pleural effusion (showing pleomorphic tumor cells with marked atypia), cell block (CB) preparation, and immunocytochemical (ICC) staining. Next-generation sequencing (NGS) of the CB specimen identified a missense mutation in MSH2 (c.14C>A, p.Pro5Gln) with a variant allele frequency (VAF) of 48%, confirming the feasibility of CB as an alternative specimen for molecular testing. The patient received chemotherapy combined with radiotherapy and remained in stable clinical condition. Cytopathology offers a valuable diagnostic approach for patients with primary cardiac tumors in whom histological sampling cannot be obtained, and molecular testing using CB specimens can provide additional insights into the genetic profile of such rare tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.